Newly Diagnosed Cutaneous T-Cell Lymphoma (CTCL)
Cutaneous T-Cell Lymphoma - Yale Medicine Explains
Update on Cutaneous T-Cell Lymphoma | Lymphoma Research Foundation Webinars
Pathology Grand Rounds - Cutaneous T-Cell Lymphoma | Dr. Michi Shinohara
Update on Cutaneous T-Cell Lymphoma | LRF Webinars
Mogamulizumab demonstrates significant improvement in progression free survival for CTCL
Facebook Live: Stress and Its Impact on Cutaneous Lymphoma
Treating Cutaneous T-cell Lymphoma
A Patient Story
First-in-human study of IPH4102 for relapsed cutaneous T-cell lymphoma
ALCANZA: brentuximab vedotin improves ORR and PFS in CTCL
Mycosis Fungoides (Cutaneous T-Cell Lymphoma): 5-Minute Pathology Pearls
What Are The Survival Rates For Lymphoma?
Immune checkpoint inhibitors for cutaneous T-cell lymphoma
Cutaneous T-cell Lymphoma
Rare Variant: Primary Cutaneous Gamma/Delta T-cell Lymphoma
Cutaneous T cell lymphomas
DIAGNOSIS, STAGING AND MANAGEMENTOF CUTANEOUS T-CELL LYMPHOMA (CTCL) - PROF. JULIA SCARISBRICK
International Patient Conference 2022 - Basics of Cutaneous Lymphoma (in English)
Efficacy of Brentuximab Vedotin in Treating Cutaneous T-cell Lymphoma